Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Viviana Maria Gianguzzo"'
Autor:
Giuseppe Cicala, Michelangelo Rottura, Viviana Maria Gianguzzo, Federica Cristiano, Selene Francesca Anna Drago, Giovanni Pallio, Natasha Irrera, Egidio Imbalzano, Edoardo Spina, Vincenzo Arcoraci
Publikováno v:
Pharmaceuticals, Vol 17, Iss 10, p 1365 (2024)
Introduction: The discovery of serine protease proprotein convertase subtilisin-kexin type 9 (PCSK9) has revolutionized pharmacological lipid-lowering treatments. The first PCSK9 antagonists (PCSK9-A), evolocumab and alirocumab, were approved in 2015
Externí odkaz:
https://doaj.org/article/163ee951ebe44597bb3b14b6b7c86479
Autor:
Michelangelo Rottura, Selene Francesca Anna Drago, Viviana Maria Gianguzzo, Antonino Molonia, Giovanni Pallio, Riccardo Scoglio, Sebastiano Marino, Angela Alibrandi, Egidio Imbalzano, Francesco Squadrito, Natasha Irrera, Vincenzo Arcoraci
Publikováno v:
Heliyon, Vol 10, Iss 10, Pp e30787- (2024)
Aims: the aim of the study was to analyze glomerular filtration ratio (GFR) changes in diabetic patients assisted by General Practitioners (GPs) evaluating the risk factors related to glomerular function. Methods: patients with diabetes with at least
Externí odkaz:
https://doaj.org/article/09ffd9c9ee0a418891d8716331a26fd1
Autor:
Selene Francesca Anna Drago, Michelangelo Rottura, Antonino Molonia, Viviana Maria Gianguzzo, Giovanni Pallio, Natasha Irrera, Luana Orlando, Marianna Gigliotti De Fazio, Marilena Isgrò, Natalia Zirilli, Vincenzo Arcoraci, Egidio Imbalzano
Publikováno v:
Pharmaceuticals, Vol 17, Iss 6, p 779 (2024)
Chronic venous insufficiency (CVI) represents a risk factor for cardiovascular events. The first-line treatment includes the use of compression stockings and lifestyle changes. Natural products, such as flavonoids, could be used to improve the effect
Externí odkaz:
https://doaj.org/article/dff0cde4880242d59d2c3bc8a3d6b065